I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ASRS 2025

-
Coming soon
03:00 PM
Duration 10mins Long Beach Convention Center
Machine Learning–Based 3D Volumetric Analysis of Pigment Epithelial Detachment Reduction With Faricimab▼ vs Aflibercept in TENAYA/LUCERNE
Yoshihiro Yonekawa, Lanzetta P, Albrecht T, Harrell E, Hibar D, Lu H, Patel S, Yang M, Margaron P

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 10mins Long Beach Convention Center
Faricimab▼ Real-World Data Support Clinical Trial Data in Patients With Treatment-Naïve nAMD: Results From TENAYA/LUCERNE and FARETINA/FARWIDE
Sara Haug, Avery R, Souied E, Bonine N, Dayal P, Kotecha A, Margaron P, Yang M

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 10mins Long Beach Convention Center
Predictors of Extended Treatment Intervals in Patients With DME Treated With Faricimab▼ in the Phase 3 YOSEMITE/RHINE Trials
Michael Klufas, Gerendas B, Ambresin A, Arevalo J F, Gibson K, Sim D, Yang M

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 10mins Long Beach Convention Center
Global Real-World Clinical and Anatomical Outcomes With Faricimab▼ in Treatment-Naïve Patients With nAMD or DME: The VOYAGER Study
Aboobaker S, Schmitz-Valckenberg S, Bailey C, Chaikitmongkol V, Chaudhary V, Chi GC, Downey A, Finger RP, Koh A HC, Ishida S, Lövestam-Adrian M, Parravano M, Luna Pinto JD, Sheth V, Shi B, Souied EH, Uschner D, Guymer R

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 10mins Long Beach Convention Center
Real-World Outcomes of Faricimab▼ in nAMD From the UK: 18-Month Results From the FARWIDE-nAMD Study
Praveen Patel, Varma D, Talks J, De Salvo G, De Silva S, Gale R, McKibbin M, Chi G, James N, Downey A, Dodds M, Dayal P

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 10mins Long Beach Convention Center
Real-World Outcomes of Faricimab▼ in DME From the UK: 1-Year Results From the FARWIDE-DME Study
Ian Pearce, Peto T, Sivaprasad S, Reynolds R, Bailey C, Downey L,Kiire C, Chi G, James N, Downey A, Dodds M, Dayal P

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 10mins Long Beach Convention Center
Association of Early Macular Leakage Resolution With Extended Dosing Intervals in Patients With RVO: A BALATON/COMINO Post Hoc Analysis
Carl Danzig, Bhatt H, Dagincourt N, Pereira L P, Schweitzer J, Thommen J

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 10mins Long Beach Convention Center
Real-World Survey on Physician Preferences and Dosing Schedules for Anti-VEGF Therapies in the Treatment of nAMD
Shilpa Gulati, Ko S, Bonine N, Coak E, Mascia D, Li K

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 10mins Long Beach Convention Center
Fluctuations in Pigment Epithelial Detachment Thickness in the Archway Phase 3 Trial of the PDS
Malik D, Brodie F, Graff J, Lai T, Ruiz Medrano J, Priglinger S, Blotner, Gordon A, Holekamp N, Prager, A Heinrich D

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 10mins Long Beach Convention Center
Impact of the Optimization of Surgical Procedure on the Incidence of Endophthalmitis and Associated Outcomes of Patients in PDS Trials
Chang M, Chaudhry N, Campochiaro P, Pieramici D, Regillo C, Bobbala A, Gune S, Jaycock P, Kardatzke D, Prager A, Singh N

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 10mins Long Beach Convention Center
Mitigating Conjunctival Erosions in Patients Treated With the PDS: Surgical Management and Clinical Outcomes
Suan E, Klufas M, Regillo C, Awh C, Gordon A, Blotner S, Prager A, Singh N, Utley S, Gune S

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 10mins Long Beach Convention Center
Clinical Impact of Continuous Drug Delivery via the PDS in Retinal Diseases
Arevalo JF, Graff J, Campochiaro P, Chakravarthy U, Emanuelli A, Gill M, Rachitskaya A, Wirthlin R, Blotner S, Gune S, Singh N

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 10mins Long Beach Convention Center
Real-World Treatment Patterns and Ocular Morbidity in Patients With Uveitic Macular Edema Secondary to Noninfectious Uveitis in the United States
Uchiyama E, Chen L, Dayal P, Pal N, Stoilov I, Mesquida M, Haskova Z, Steeples L

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
05:51 PM
Duration 3mins Long Beach Convention Center
Volumetric Analysis of Hard Exudates on Optical Coherence Tomography: Biomarker Results of Faricimab▼ vs Aflibercept From Phase 3 YOSEMITE/RHINE
Murtaza Adam, Vujosevic S, Pollreisz A, Dinah C, Goldberg R, Ip M, Rahimy E, Amador M, Bachmeier I, Gibson K, Maunz A, O'Leary O, Uschner D

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
05:54 PM
Duration 3mins Long Beach Convention Center
Treatment Response and Safety of Faricimab▼ in Underrepresented Patients With DME: Year 1 Results From ELEVATUM in the US
Andres Emanuelli, Amador M, Brown J, Coney J, Cunningham M, Gonzalez L, Huddleston S,Scott A, Milunovich S, Yang M, Lu X-Y

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
05:57 PM
Duration 3mins Long Beach Convention Center
Update on Faricimab▼ for DME: New Clinical Features of Eyes in the RHONE-X Long-Term Extension Study
Veeral Sheth, Arshad M. Khanani, Cheryl Jones, Kara Gibson, Timothy Y. Y. Lai, Ian Pearce, Patricio Schlottmann, Dawn A. Sim

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
06:09 PM
Duration 3mins Long Beach Convention Center
Comparability of Diabetic Retinopathy Severity Evaluation on Gold Standard vs Ultrawide Field Images in YOSEMITE/RHINE Phase 3 Studies
Blodi B, Domalpally A, Tang Y, Willis J, Gibson K, Khanani A, Wykoff C, Haskova Z

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
06:38 PM
Duration 3mins Long Beach Convention Center
Impact of PDS in Study Eyes vs Intravitreal Injections in Fellow Eyes in Pagoda Trial Patients With Bilateral Diabetic Macular Edema (DME)
Graff J, Eichenbaum, D, Wirthlin R, Yi-Ting Hsieh, Jason Hsu, Patricia Udaondo, Heinrich D, Gune S, Blotner S, Jones M, Schimpl A, Santhanankrishnan A

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
12:37 AM
Duration 60mins California, USA
Quantitative Ultra-Widefield Fluorescein Angiography for the Assessment of Novel Biomarkers of Vascular Stability With Faricimab▼ in YOSEMITE/RHINE
Karen Matar, Justis Ehlers, Indurkar A, Della Vecchia L, Amine R, Mamone J, Tang A, Gibson K, Dagincourt N, Mar F, Amador M, Warter A, Sim D

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins California, USA
Zifibancimig Administered via Intravitreal Injection and the Port Delivery Platform in Patients With nAMD: Rationale and Design of the Burgundy Study
Wolfe J, Haug S, Dhoot D, Kim J, Kwong M, Callaway N, Orduna J, Steiert B, Wollenhaupt M, Wentzel C

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
05:35 PM
Duration 3mins Long Beach Convention Center
Baseline and Early Treatment Response Variables Associated With Faricimab▼ Durability in Treatment-Naïve nAMD: TENAYA/LUCERNE Post Hoc Analyses
Ben Bakall, Tan C, Gallego-Pinazo R, Koh A, Pitcher J, Yang M, Patel S, Margaron P

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
05:44 PM
Duration 3mins Long Beach Convention Center
Indirect Comparison of the Relative Effectiveness of Faricimab▼ vs Aflibercept 8 mg in DME and nAMD
Nik London, Keane P, Holekamp N, Leng T,Siedlecki J, Mar F, Gibson K, Margaron P, Buehrer C, Tabano D

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
05:47 PM
Duration 3mins Long Beach Convention Center
Five Year Outcomes in nAMD Patients Enrolled in the Archway Study and Treated With the PDS
Kitchens J, Andrea-Thanei G, Blotner S, Gune S, Rabena M, Singh N

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar